ClinOps Consulting: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ClinOps Consulting
Largest movements
- Current investments +€122,567
up €122,567 (+21.6%), from €568,083 to €690,650
- Receivables within one year -€42,518
down €42,518 (-69.9%), from €60,858 to €18,340
of which Trade receivables: -€36,163
- Reserves +€105,551
up €105,551 (+16.6%), from €636,459 to €742,010
- Other debts -€26,753
down €26,753 (-83.3%), from €32,100 to €5,347
- Gross operating margin -€69,311
down €69,311 (-31.4%), from €220,411 to €151,100
- Taxes -€21,618
down €21,618 (-33.2%), from €65,113 to €43,495
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €688,029 | €764,793 | +€76,764 | +11.2% |
| Fixed assets | 21/28 | €4,554 | €4,110 | -€445 | -9.8% |
| Tangible fixed assets | 22/27 | €4,554 | €4,110 | -€445 | -9.8% |
| Plant, machinery and equipment | 23 | €2,599 | €1,394 | -€1,205 | -46.4% |
| Furniture and vehicles | 24 | €1,955 | €2,716 | +€761 | +38.9% |
| Current assets | 29/58 | €683,474 | €760,683 | +€77,209 | +11.3% |
| Amounts receivable within one year | 40/41 | €60,858 | €18,340 | -€42,518 | -69.9% |
| Trade receivables | 40 | €51,460 | €15,297 | -€36,163 | -70.3% |
| Other amounts receivable | 41 | €9,398 | €3,043 | -€6,355 | -67.6% |
| Current investments | 50/53 | €568,083 | €690,650 | +€122,567 | +21.6% |
| Cash at bank and in hand | 54/58 | €53,768 | €50,966 | -€2,802 | -5.2% |
| Deferred charges and accrued income | 490/1 | €766 | €727 | -€39 | -5.1% |
| Total equity and liabilities | 10/49 | €688,029 | €764,793 | +€76,764 | +11.2% |
| Equity | 10/15 | €636,459 | €742,010 | +€105,551 | +16.6% |
| Contributions | 10/11 | €0 | - | = | |
| Reserves | 13 | €636,459 | €742,010 | +€105,551 | +16.6% |
| Distributable reserves | 133 | €636,459 | €742,010 | +€105,551 | +16.6% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €51,570 | €22,783 | -€28,787 | -55.8% |
| Amounts payable within one year | 42/48 | €51,570 | €22,116 | -€29,454 | -57.1% |
| Financial debts | 43 | €4,354 | €2,081 | -€2,273 | -52.2% |
| Credit institutions | 430/8 | €0 | - | = | |
| Other loans | 439 | €4,354 | €2,081 | -€2,273 | -52.2% |
| Trade debts | 44 | €2,003 | €1,574 | -€429 | -21.4% |
| Suppliers | 440/4 | €2,003 | €1,574 | -€429 | -21.4% |
| Taxes, remuneration and social security | 45 | €13,113 | €13,113 | = | 0.0% |
| Taxes | 450/3 | €13,113 | €13,113 | = | 0.0% |
| Other amounts payable | 47/48 | €32,100 | €5,347 | -€26,753 | -83.3% |
| Accrued charges and deferred income | 492/3 | - | €667 | +€667 | |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €1,114 | - | -€1,114 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,760 | €2,385 | +€625 | +35.5% |
| Other operating charges | 640/8 | €1,337 | €745 | -€592 | -44.3% |
| Gross operating margin | 9900 | €220,411 | €151,100 | -€69,311 | -31.4% |
| Operating profit (loss) | 9901 | €216,199 | €147,970 | -€68,229 | -31.6% |
| Financial income | 75/76B | €357 | €2,177 | +€1,820 | +510% |
| Recurring financial income | 75 | €357 | €2,177 | +€1,820 | +510% |
| Financial charges | 65/66B | €673 | €1,101 | +€429 | +63.8% |
| Recurring financial charges | 65 | €673 | €1,101 | +€429 | +63.8% |
| Profit (loss) for the period before taxes | 9903 | €215,883 | €149,046 | -€66,837 | -31.0% |
| Income taxes | 67/77 | €65,113 | €43,495 | -€21,618 | -33.2% |
| Profit (loss) for the period | 9904 | €150,770 | €105,551 | -€45,219 | -30.0% |
| Profit (loss) for the period to be appropriated | 9905 | €150,770 | €105,551 | -€45,219 | -30.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.